Allianz Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $150M | Buy |
2,393,824
+394,232
| +20% | +$31.5M | 0.16% | 126 |
|
|
2025
Q4 | $191M | Buy |
1,999,592
+508,046
| +34% | +$49.8M | 0.19% | 91 |
|
|
2025
Q3 | $146M | Sell |
1,491,546
-349,670
| -19% | -$36.2M | 0.16% | 116 |
|
|
2025
Q2 | $198M | Buy |
1,841,216
+451,135
| +32% | +$45.6M | 0.24% | 87 |
|
|
2025
Q1 | $140M | Buy |
1,390,081
+275,871
| +25% | +$27.8M | 0.18% | 104 |
|
|
2024
Q4 | $99.5M | Buy |
1,114,210
+152,349
| +16% | +$13.4M | 0.13% | 156 |
|
|
2024
Q3 | $80.6M | Buy |
961,861
+15,930
| +2% | +$1.26M | 0.11% | 195 |
|
|
2024
Q2 | $72.8M | Buy |
945,931
+9,049
| +1% | +$662K | 0.11% | 195 |
|
|
2024
Q1 | $64.2M | Sell |
936,882
-20,164
| -2% | -$1.3M | 0.1% | 219 |
|
|
2023
Q4 | $55.3M | Buy |
957,046
+315,446
| +49% | +$16.8M | 0.09% | 222 |
|
|
2023
Q3 | $33.9M | Buy |
641,600
+10,718
| +2% | +$562K | 0.06% | 342 |
|
|
2023
Q2 | $34.1M | Buy |
630,882
+251,214
| +66% | +$13.1M | 0.06% | 306 |
|
|
2023
Q1 | $19M | Buy |
379,668
+124,217
| +49% | +$5.85M | 0.03% | 495 |
|
|
2022
Q4 | $11.8M | Sell |
255,451
-19,628
| -7% | -$850K | 0.02% | 630 |
|
|
2022
Q3 | $10.7M | Sell |
275,079
-725,495
| -73% | -$29.1M | 0.02% | 647 |
|
|
2022
Q2 | $37.3M | Buy |
1,000,574
+126,988
| +15% | +$5.17M | 0.04% | 493 |
|
|
2022
Q1 | $38.7M | Sell |
873,586
-193,810
| -18% | -$8.4M | 0.03% | 540 |
|
|
2021
Q4 | $45.4M | Sell |
1,067,396
-8,511
| -0.8% | -$358K | 0.03% | 499 |
|
|
2021
Q3 | $46.7M | Buy |
1,075,907
+70,671
| +7% | +$3.13M | 0.04% | 454 |
|
|
2021
Q2 | $43M | Sell |
1,005,236
-137,802
| -12% | -$5.8M | 0.04% | 430 |
|
|
2021
Q1 | $44.2M | Sell |
1,143,038
-420,049
| -27% | -$15.9M | 0.04% | 398 |
|
|
2020
Q4 | $56.2M | Sell |
1,563,087
-2,843,594
| -65% | -$102M | 0.06% | 328 |
|
|
2020
Q3 | $168M | Sell |
4,406,681
-31,661
| -0.7% | -$1.22M | 0.2% | 124 |
|
|
2020
Q2 | $156M | Sell |
4,438,342
-387,399
| -8% | -$14M | 0.18% | 122 |
|
|
2020
Q1 | $157M | Sell |
4,825,741
-2,198,762
| -31% | -$85.9M | 0.21% | 110 |
|
|
2019
Q4 | $318M | Sell |
7,024,503
-610,369
| -8% | -$25.5M | 0.29% | 61 |
|
|
2019
Q3 | $311M | Sell |
7,634,872
-821,887
| -10% | -$34.8M | 0.3% | 53 |
|
|
2019
Q2 | $363M | Sell |
8,456,759
-478,268
| -5% | -$18.4M | 0.34% | 50 |
|
|
2019
Q1 | $343M | Sell |
8,935,027
-434,979
| -5% | -$16.6M | 0.34% | 53 |
|
|
2018
Q4 | $331M | Buy |
9,370,006
+3,671,401
| +64% | +$133M | 0.36% | 49 |
|
|
2018
Q3 | $219M | Buy |
5,698,605
+5,117,950
| +881% | +$179M | 0.2% | 96 |
|
|
2018
Q2 | $19M | Buy |
580,655
+31,123
| +6% | +$939K | 0.02% | 911 |
|
|
2018
Q1 | $15M | Sell |
549,532
-1,009,203
| -65% | -$27.4M | 0.01% | 1036 |
|
|
2017
Q4 | $38.6M | Buy |
1,558,735
+310,154
| +25% | +$8.55M | 0.03% | 642 |
|
|
2017
Q3 | $36.4M | Buy |
1,248,581
+2,622
| +0.2% | +$72.4K | 0.03% | 651 |
|
|
2017
Q2 | $34.5M | Sell |
1,245,959
-432,129
| -26% | -$11.5M | 0.03% | 693 |
|
|
2017
Q1 | $41.7M | Sell |
1,678,088
-412,768
| -20% | -$10M | 0.04% | 591 |
|
|
2016
Q4 | $45.2M | Buy |
2,090,856
+630,370
| +43% | +$13.8M | 0.04% | 596 |
|
|
2016
Q3 | $34.7M | Buy |
1,460,486
+570,159
| +64% | +$13.6M | 0.03% | 655 |
|
|
2016
Q2 | $20.8M | Sell |
890,327
-38,503
| -4% | -$833K | 0.02% | 871 |
|
|
2016
Q1 | $17.5M | Buy |
928,830
+93,882
| +11% | +$1.65M | 0.02% | 857 |
|
|
2015
Q4 | $15.4M | Buy |
834,948
+52,758
| +7% | +$945K | 0.02% | 878 |
|
|
2015
Q3 | $12.8M | Sell |
782,190
-2,193,276
| -74% | -$37.5M | 0.02% | 878 |
|
|
2015
Q2 | $52.7M | Sell |
2,975,466
-785,551
| -21% | -$14M | 0.06% | 416 |
|
|
2015
Q1 | $66.8M | Buy |
3,761,017
+1,265,494
| +51% | +$20M | 0.08% | 292 |
|
|
2014
Q4 | $33.1M | Sell |
2,495,523
-1,738,733
| -41% | -$22.2M | 0.04% | 526 |
|
|
2014
Q3 | $50M | Buy |
4,234,256
+218,420
| +5% | +$2.75M | 0.06% | 357 |
|
|
2014
Q2 | $51.3M | Buy |
4,015,836
+2,673,570
| +199% | +$34.8M | 0.06% | 343 |
|
|
2014
Q1 | $18.1M | Buy |
1,342,266
+1,137,520
| +556% | +$14.9M | 0.02% | 577 |
|
|
2013
Q4 | $2.46M | Sell |
204,746
-18,498
| -8% | -$219K | ﹤0.01% | 1150 |
|
|
2013
Q3 | $2.62M | Buy |
223,244
+179,505
| +410% | +$1.94M | ﹤0.01% | 1115 |
|
|
2013
Q2 | $405K | Buy |
+43,739
| New | +$371K | ﹤0.01% | 1513 |
|
Other funds holding BSX
VCM
VPM
Allianz Asset Management's BSX Position: Q1 2026 in Review
Allianz Asset Management increased its Boston Scientific (BSX) stake by 20% in Q1 2026, buying an estimated $31.5M and bringing the position to 2,393,824 shares worth $150M. The position accounts for 0.16% of the portfolio, ranked #126.
Allianz Asset Management first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $363M in Q2 2019. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Allianz Asset Management held 2,393,824 shares of Boston Scientific worth $150M as of Q1 2026.
- Allianz Asset Management bought 394,232 Boston Scientific shares in Q1 2026, an estimated $31.5M.
- Boston Scientific made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #126 holding.
- Allianz Asset Management first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Boston Scientific position peaked at $363M in Q2 2019.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.